Law Offices of Howard G. Smith Reminds Investors of Lead Plaintiff Deadlines in Securities Fraud Class Actions Against Erasca, Nano-X, Microsoft, and Black Rock Coffee Bar

GlobeNewswire··Read original
2▲0 ▼4Impact / 5
Summary · why it matters

The Law Offices of Howard G. Smith reminds investors that securities fraud class action lawsuits have been filed against Erasca, Nano-X Imaging, Microsoft, and Black Rock Coffee Bar, with lead plaintiff deadlines approaching in August 2026. For Erasca, the class period runs from January 14, 2025 to April 26, 2026, with a deadline of August 10, 2026, and the complaint alleges that preclinical data for ERAS-0015 was based on improper comparisons and risked patent and trade secret violations. Nano-X Imaging faces a class period from March 31, 2025 to April 17, 2026, with a deadline of August 11, 2026, and allegations that the company overstated efficiency gains and demand while its production was poorly aligned with demand, leading to increased expenses and restructuring charges. Microsoft's class period is May 1, 2025 to January 28, 2026, with a deadline of August 11, 2026, and the complaint claims that Copilot products suffered from brand positioning and interoperability problems, the company's AI model ranked below competitors, and it failed to convert a significant percentage of commercial Microsoft 365 users to paid Copilot subscriptions. Black Rock Coffee Bar's class period runs from September 12, 2025 to May 12, 2026, with a deadline of August 17, 2026, and the complaint alleges that new store openings cannibalized existing revenue and the company overstated how its expansion strategy avoided sales transfer. Investors who suffered losses can contact the Law Offices of Howard G. Smith to discuss their legal rights.

Impact on assets 4

Artificial Intelligence▼ · 2 stocks
Microsoft Corporation
MSFT
▼ NegativeRegulationrelevance

Securities fraud class action alleges Copilot products had brand positioning and interoperability problems, AI model ranked below competitors, and low conversion to paid subscriptions.

Nano X Imaging Ltd
NNOX
▼ NegativeRegulationrelevance

Securities fraud class action alleges overstated efficiency gains and demand, and poor production alignment leading to increased expenses and restructuring charges.

Consumer Staples▼ · 1 stocks
Biotech & Genomic Medicine▼ · 1 stocks
Erasca Inc
ERAS
▼ NegativeRegulationrelevance

Securities fraud class action alleges preclinical data for ERAS-0015 was based on improper comparisons and risked patent/trade secret violations.

© 2026 MarketIVNews